IPO News & Commentary
Get the latest insights on new stocks
- Parkinson’s disease biotech Aspen Neuroscience prices IPO at $15, the low end of the range 10/30/26
- Emerging markets fintech OPay prices US IPO at $19, the low end of the range 10/30/26
- Immunology and inflammation biotech Bambusa Therapeutics prices upsized IPO at $16 midpoint 10/30/26
- Singapore-based logistics firm Tracx Logis cuts deal size by 33% ahead of $20 million US IPO 10/29/26
- Dallas-area stone countertop fabricator KAT Construction Services files for a $20 million IPO 10/29/26
- SPAC Redwoods Acquisition II files for a $75 million IPO, targeting energy storage, telecom, and consumer businesses 10/29/26
- Natural pest control maker Med-X increases shares registered by 23% ahead of Nasdaq direct listing 10/29/26
See more
IPO News By Industry
- Singapore-based logistics firm Tracx Logis cuts deal size by 33% ahead of $20 million US IPO 10/29/26
- Dallas-area stone countertop fabricator KAT Construction Services files for a $20 million IPO 10/29/26
- Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO 10/20/26
- US IPO Week Ahead: November’s IPO market set for a quiet start 10/30/26
- SPAC UCSB Acquisition files for a $60 million IPO, targeting businesses with competitive advantages and growth potential 10/30/26
- SPAC Redwoods Acquisition II files for a $75 million IPO, targeting energy storage, telecom, and consumer businesses 10/29/26
NYSE IPO News
- Emerging markets fintech OPay prices US IPO at $19, the low end of the range 10/30/26
- SPAC Aimei Health Technology II increases unit offering by 67% ahead of $100 million IPO 10/26/26
- US IPO Week Ahead: Africa-focused fintech targets US IPO as Anthropic makes its filing public 10/23/26
- Emerging markets fintech OPay sets terms for $320 million US IPO 10/23/26
- Africa-linked IPOs pick up steam in 2026 10/20/26
Nasdaq IPO News
- US IPO Week Ahead: November’s IPO market set for a quiet start 10/30/26
- US IPO Weekly Recap: Anthropic files for potentially record-breaking IPO 10/30/26
- SPAC UCSB Acquisition files for a $60 million IPO, targeting businesses with competitive advantages and growth potential 10/30/26
- Parkinson’s disease biotech Aspen Neuroscience prices IPO at $15, the low end of the range 10/30/26
- Immunology and inflammation biotech Bambusa Therapeutics prices upsized IPO at $16 midpoint 10/30/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
US IPO Week Ahead: November’s IPO market set for a quiet start
Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. A number of sizable companies are on file and eligible to launch in the week ahead, before Anthropic is expected to...read more
US IPO Weekly Recap: Anthropic files for potentially record-breaking IPO
Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. However, the week’s most notable news came from Anthropic (ANT), which filed its long awaited S-1 on Monday for an IPO that could be the largest ever. ...read more
SPAC UCSB Acquisition files for a $60 million IPO, targeting businesses with competitive advantages and growth potential
UCSB Acquisition, a blank check company led by Chinese executives, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million units at $10. Each unit consists of one...read more